MDX-11

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMDX-11

Drug Alias NameAnti-AML/SCCL-trigger monoclonal antibodyAnti-CD15 monoclonal antibody PM-81Monoclonal antibody PM-81MDX-11

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAnti-CD15Radionuclide imaging enhancersSingle-photon emission-computed tomography enhancers

Targets3-fucosyl-N-acetyl-lactosamine

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMedarex Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMedarex Inc

Active IndicationsN/A

Inactive IndicationsLeukemia, Myeloid, Acute

ATC CodeN/A